{
    "organizations": [],
    "uuid": "18701af7b7f4df81013b4651da2561e73e18b5e4",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-dyadic-international-announces-rd/brief-dyadic-international-announces-rd-collaboration-with-mitsubishi-tanabe-pharma-corp-idUSFWN1QH11Q",
    "ord_in_thread": 0,
    "title": "BRIEF-Dyadic International Announces R&D Collaboration With Mitsubishi Tanabe Pharma Corp",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 27 (Reuters) - Mitsubishi Tanabe Pharma Corp:\n* ANNOUNCES RESEARCH AND DEVELOPMENT COLLABORATION WITH MITSUBISHI TANABE PHARMA CORPORATION TO PRODUCE TWO TARGET PROTEINS IN C1\n* ANNOUNCES RESEARCH AND DEVELOPMENT COLLABORATION WITH MITSUBISHI TANABE PHARMA CORPORATION TO PRODUCE TWO TARGET PROTEINS IN C1 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-27T21:44:00.000+02:00",
    "crawled": "2018-02-28T12:46:56.010+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "mitsubishi",
        "tanabe",
        "pharma",
        "corp",
        "announces",
        "research",
        "development",
        "collaboration",
        "mitsubishi",
        "tanabe",
        "pharma",
        "corporation",
        "produce",
        "two",
        "target",
        "protein",
        "c1",
        "announces",
        "research",
        "development",
        "collaboration",
        "mitsubishi",
        "tanabe",
        "pharma",
        "corporation",
        "produce",
        "two",
        "target",
        "protein",
        "c1",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}